课题基金 / 基金详情

Investigating the Mechanism and Effect of Disease-Associated Increases in the Huntingtin Long 3'UTR Isoform

Investigating the Mechanism and Effect of Disease-Associated Increases in the Huntingtin Long 3'UTR Isoform
研究亨廷顿蛋白长 3UTR 亚型与疾病相关的增加的机制和影响
批准号:
9047831
负责人:
Lindsay Sara Romo
金额:
$2.97万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-17 至 2019-09-16

项目摘要

项目成果

Lindsay Sara Romo的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(申请人提供):亨廷顿病是一种毁灭性的神经退行性疾病,由亨廷顿蛋白(HTT)基因中的一个扩大的三核苷酸重复序列翻译成一种神经毒性蛋白而引起。尽管研究人员正在开发小干扰RNA来靶向和降解突变的mRNA,但目前还没有有效的治疗或治愈方法。因为正常的HTT蛋白对神经元的生存是必不可少的,所以治疗的目标是避免野生型mRNA。如果突变和野生型等位基因在转录后被不同的处理,那么有可能特异性地针对突变的mRNA。研究表明,突变型和野生型表现出不同的稳定性和定位,但其机制尚不清楚。一种可能是突变的mRNA被加工成不同的亚型,具有不同的定位和稳定性。突变型和野生型HTT以两种3‘非编码区亚型存在。事实上,初步数据表明,突变的信使核糖核酸比野生型信使核糖核酸更有可能作为较长的异构体存在。这项拟议的工作旨在确定突变型和野生型HTT 3‘UTR亚型差异的机制和影响。由于突变位于交替多聚腺苷(APA)相关基因区域的近端,扩展可能会破坏突变的HTT APA,并导致向更长的异构体转变。如果是这样的话,其他的mRNA和另一个等位基因应该被正常处理。为了确定异构体长度的变化是否是HTT特有的,将通过qPCR和深度测序在杂合子人类样本中评估HTT和其他APA mRNAs的长度。为了验证扩增是否起作用,将通过qPCR从有或没有扩增的转染质粒中测量异构体长度。为了评估HTT亚型长度是否在APA期间或之后发生变化,将在用修饰的核苷酸标记新转录的mRNA后立即或很长时间内评估来自质粒的HTT亚型的长度。这些研究是特定目标1的重点。突变的HTT亚型长度的变化可能会影响下游加工,因为3‘UTR包含许多指导mRNA稳定性和定位的基序。为了验证这一点,将通过转录抑制和qPCR(衰变)或荧光原位杂交(定位)来检测突变和野生型HTT亚型在正常细胞和疾病细胞中的衰变和定位。为了验证差异是由于亚型长度的不同,将在单个HTT亚型转染的细胞模型中分析亚型定位和衰变。这些研究是特定目标2的重点。这些研究将共同阐明突变型和野生型mRNAAPA、衰变和定位的差异。然后,可以设计针对突变异构体特有的mRNA区域或细胞室的等位基因特异性小RNA,从而改进对这种毁灭性疾病的治疗。
英文摘要
 DESCRIPTION (provided by applicant): Huntington's disease is a devastating neurodegenerative disorder caused by translation of an expanded trinucleotide repeat in the huntingtin (HTT) gene into a neurotoxic protein. There is no effective treatment or cure, although researchers are developing small interfering RNAs to target and degrade mutant mRNA. Because the normal HTT protein is essential for neuronal survival, therapies aim to spare wild-type mRNA. It may be possible to specifically target the mutant mRNA if mutant and wild-type alleles are processed differently after transcription. Research indicates mutant and wild-type mRNA exhibit different stability and localization, but the mechanism is unknown. One possibility is mutant mRNA is processed into a different isoforms with different localization and stability. Mutant and wild-type HTT mRNA are present as two 3'UTR isoforms. Indeed, preliminary data suggest mutant mRNA is more likely than wild-type mRNA to be present as the longer isoform. The proposed work aims to determine the mechanism and impact of differences in mutant and wild-type HTT 3'UTR isoforms. Because the mutation is proximal to gene regions involved in alternative polyadenylation (APA), the expansion may disrupt mutant HTT APA and cause the shift to the longer isoform. If so, other mRNAs and the other allele should be processed normally. To determine if the change in isoform length is HTT-specific, the length of HTT and other APA mRNAs will be assessed in heterozygous human samples by qPCR and deep sequencing. To verify the expansion is responsible, isoform lengths will be measured by qPCR from a transfected plasmid with or without the expansion. To assess whether the HTT isoform length changes during or after APA, the length of HTT isoforms from the plasmid will be assessed right after or much after labeling newly transcribed mRNAs with a modified nucleotide. These studies are the focus of Specific Aim 1. The change in mutant HTT isoform length likely impacts downstream processing because the 3'UTR contains many motifs directing mRNA stability and localization. To test this, the decay and localization of mutant and wild-type HTT isoforms will be assayed in normal and disease cells by transcriptional arrest and qPCR (decay) or fluorescent in-situ hybridization (localization). To verify differences are due to the isoform length, isoform localization and decay will be assayed in cell models transfected with a single HTT isoform. These studies are the focus of Specific Aim 2. Together, these studies will elucidate differences in mutant and wild-type mRNA APA, decay, and localization. Allele-specific small RNAs could then be designed to target mRNA regions or cellular compartments unique to the mutant isoform, improving treatment of this devastating disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the Mechanism and Effect of Disease-Associated Increases in the Huntingtin Long 3'UTR Isoform
海外基金